M&A Month in Review
Global Private Equity, April 2013
The value of global private equity investment rose during April to reach one of its best results of the last 12 months under review, while volume also advanced month-on-month.
Read more...
Cleantech, April 2013
The value of private equity and venture capital investment in the cleantech sector dipped for the fourth month in a row in April 2013 to reach its lowest point of the last 12 months under review.
Read more...
Biotech, April 2013
After a disappointing set of results for the first three months of the year, the value and volume of private equity and venture capital investment in the biotech sector leapt in April to reach the highest and third highest level of the last 12 months, respectively.
Read more...
Iberia, April 2013
The value of mergers and acquisitions (M&A) targeting companies based in Spain and Portugal more than doubled by value in April, with 123 deals worth EUR 12,522 million recorded for the month.
Read more...
Western Europe, April 2013
The value of mergers and acquisitions (M&A) targeting Western European companies practically doubled month-on-month to hit its third highest level in the last 12 months, despite a dip in volume.
Read more...
Middle East, April 2013
The total value of mergers and acquisitions (M&A) targeting companies based in the Middle East soared in April 2013 to USD 1,770 million from USD 347 million in March, despite weakened deal volume over the four weeks.
Read more...
North America, April 2013
There were 863 mergers and acquisitions (M&A) worth a combined USD 60,049 million targeting North American companies in April 2013, compared with 1,067 transactions at USD 52,178 million in March. Value was boosted by 15 per cent by one mega deal worth more than USD 15,000 million.
Read more...
Russia/CEE, April 2013
Mergers and acquisitions (M&A) activity targeting companies based in Central and Eastern Europe (CEE) and Russia fell in April 2013, with value slipping for the second month in a row.
Read more...
Cleantech, March 2013
The value of private equity and venture capital investment in the cleantech sector declined for the third consecutive month in March 2013 after peaking at USD 3,054 million in December 2012 in the 12 months under review.
Read more...
Biotech, March 2013
The upturn in private equity and venture capital investment targeting biotechnology companies in February was short-lived, as both volume and value fell once again in March 2013.
Read more...